About Curi Bio
Curi Bio develops human-relevant platforms integrating human cells, systems, and data to accelerate the discovery of new medicines. Curi’s human iPSC-based products and services enable scientists to build mature and predictive human iPSC-derived tissues—with a focus on cardiac, musculoskeletal, and
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-B+
Global Headquarters
Undisclosed
Tracked Since
Oct 1, 2026
Web & Domain Identity
Official Website
curibio.com
Domain Registered Date
Mar 10, 2020
Social & Network Presence
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Raised $10,000,000 · Series-B+
fundraisingfox.com
- Capital Raise
Series-A announced
fundraisingfox.com
- Milestone
Website domain registered
curibio.com
- Milestone
X account created (@Curi_Bio)
195 followers
Investors & Backers
Investor firms and individual backers were not publicly disclosed in available round filings for Curi Bio.
Funding History
Series-B+
· Dec 2, 2025
$10,000,000 fundraisingfox.com
Series-A
· Dec 29, 2021
Undisclosed fundraisingfox.com
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026